---
figid: PMC5664592__12935_2017_460_Fig4_HTML
figlink: /pmc/articles/PMC5664592/figure/Fig4/
number: F4
caption: Signal transduction pathway of the BCR-ABL fusion gene and Imatinib action.
  Imatinib selectively inhibits the tyrosine kinase activity that is responsible for
  the signaling pathway illustrated through tyrosine kinase phosphorylation of these
  interactions. Main signaling pathways associated with the oncogenic activity of
  the BCR-ABL gene is MYC, RAS, MAPK, STAT and PI3K. These pathways result in the
  inhibition of gene transcription, mitochondrial processing of apoptotic reactions
  and cytoskeletal organization culminating in an increase in abnormal cell activities
  including unimpeded proliferation, angiogenesis and enhanced cell survival. When
  Imatinib binds to the tyrosine kinase receptor it in turn deactivates these pathways
  resulting in cell death of the mutated leukemic cell (produced with Microsoft® PowerPoint®)
  [–, ]
pmcid: PMC5664592
papertitle: An overview of the role of platelets in angiogenesis, apoptosis and autophagy
  in chronic myeloid leukaemia.
reftext: Lisa Repsold, et al. Cancer Cell Int. 2017;17:89.
pmc_ranked_result_index: '100475'
pathway_score: 0.9638766
filename: 12935_2017_460_Fig4_HTML.jpg
figtitle: Signal transduction pathway of the BCR-ABL fusion gene and Imatinib action
year: '2017'
organisms: Homo sapiens
ndex: 32ac70cd-deb5-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5664592__12935_2017_460_Fig4_HTML.html
  '@type': Dataset
  description: Signal transduction pathway of the BCR-ABL fusion gene and Imatinib
    action. Imatinib selectively inhibits the tyrosine kinase activity that is responsible
    for the signaling pathway illustrated through tyrosine kinase phosphorylation
    of these interactions. Main signaling pathways associated with the oncogenic activity
    of the BCR-ABL gene is MYC, RAS, MAPK, STAT and PI3K. These pathways result in
    the inhibition of gene transcription, mitochondrial processing of apoptotic reactions
    and cytoskeletal organization culminating in an increase in abnormal cell activities
    including unimpeded proliferation, angiogenesis and enhanced cell survival. When
    Imatinib binds to the tyrosine kinase receptor it in turn deactivates these pathways
    resulting in cell death of the mutated leukemic cell (produced with Microsoft®
    PowerPoint®) [–, ]
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - AKT2
  - MAPK3
  - MAPK8
  - MAPK11
  - BRAF
  - MAPK14
  - ARAF
  - RAF1
  - AKT1
  - STAT6
  - MYC
  - MAP2K2
  - KRAS
  - MAPK9
  - MAPK12
  - HRAS
  - STAT2
  - STAT5B
  - NRAS
  - MAP2K1
  - STAT1
  - AKT3
  - MAPK10
  - STAT4
  - STAT3
  - STAT5A
  - MAPK13
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: MYC
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5664592__F4
redirect_from: /figures/PMC5664592__F4
figtype: Figure
---
